Federated Hermes
PPH icon

Federated Hermes’s VanEck Pharmaceutical ETF PPH Stock Holding History

Federated Hermes’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,750
Closed -$112K – 2334
2019
Q4 		$112K Buy
+1,750
New +$105K ﹤0.01% 1668

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WI
Wintrust Investments Chicago, Illinois $114M AUM 21.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Federated Hermes's PPH Position: Q1 2020 in Review

Federated Hermes sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2020, closing a stake of 1,750 shares — an estimated $112K sold.

Federated Hermes first reported a position in PPH in Q4 2019 and held it in 1 quarter. The position peaked at $112K in Q4 2019. 44 funds tracked by Wall St. Rank hold PPH as of Q1 2020.

  • Federated Hermes reported no remaining VanEck Pharmaceutical ETF position as of Q1 2020 after selling out during the quarter.
  • Federated Hermes sold 1,750 VanEck Pharmaceutical ETF shares in Q1 2020, an estimated $112K.
  • Federated Hermes first reported a position in VanEck Pharmaceutical ETF in Q4 2019 and held it in 1 quarter.
  • Federated Hermes's VanEck Pharmaceutical ETF position peaked at $112K in Q4 2019.
  • 44 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2020.

Based on Federated Hermes's 13F filing for Q1 2020, filed 13 May 2020.